Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Dietary Supplement
  • Participants: 14
  • Start Date: March 15, 2021
Mitochondrial Complex I Dysfunction in Prader Willi Syndrome: A New Therapeutic Target
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Biological
  • Participants: 300
  • Start Date: March 15, 2021
Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Biological
  • Participants: 30
  • Start Date: February 9, 2021
A PHASE 3 MULTICENTER, OPEN LABEL, MULTI COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOMATROPIN IN JAPANESE PARTICIPANTS WITH PRADER-WILLI SYNDROME (PWS)
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 1/Phase 2
  • Intervention Type: Dietary Supplement
  • Participants: 50
  • Start Date: January 11, 2021
Probiotics as a Long-term Treatment Strategy for Prader-Willi Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: December 9, 2020
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 26
  • Start Date: November 23, 2020
Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: October 1, 2020
Global Growth Hormone Study in Adults With Prader-Willi Syndroom
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Device, Behavioral
  • Participants: 60
  • Start Date: September 7, 2020
Communication in Prader-Willi Syndrome: Study of Emotional Control Related to Behavioral Disorders, Their Daily Repercussions and Examination of an Innovative Therapy: Transcutaneous Electrical Nerve Stimulation of the Vagus Nerve - PRACOM1
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Device
  • Participants: 60
  • Start Date: July 2020
Transcutaneous Vagus Nerve Stimulation in Children With Prader-Willi Syndrome
Clinical Trial
  • Status: Recruiting
  • Participants: 10000
  • Start Date: June 10, 2020
Rare Obesity Cohorts With Food Behavioral Disorders : Better Diagnosis for Better Treatment
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 20
  • Start Date: May 6, 2020
Effects of Therapeutic Elastic Band Training on Body Composition and Physical Capacity in Adults With Prader-Willi Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 48
  • Start Date: March 10, 2020
Oxytocin Treatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Study of Safety and Efficacy on Oral and Social Skills and Feeding Behavior of Intranasal Administration of Oxytocin vs Placebo
Showing 1-12 of 28